REP-9C REPLICor

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameREP-9C REPLICor
Drug Alias Nameantihypercholesterolemia agent (REPLICor)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionLDL cholesterol modulators
TargetsLDL cholesterol
Therapy Area/IndicationsHypercholesterolemiaLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReplicor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReplicor Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A